Niagen Bioscience (NAGE) Debt Ratio (2016 - 2018)
Niagen Bioscience (NAGE) posted quarterly Debt Ratio of 0.0 for Q4 2018, down 34.36% year-over-year from 0.0 in Q4 2017, and down 34.36% quarter-over-quarter from 0.0 in Q4 2017.
Niagen Bioscience (NAGE) Debt Ratio (2016 - 2018) Analysis & Trends
Niagen Bioscience (NAGE) has reported Debt Ratio for 3 consecutive years, with 0.0 the latest figure, recorded in Q4 2018.
- In Q4 2018, Debt Ratio fell 34.36% year-over-year to 0.0; the TTM figure through Dec 2018 stood at 0.0 (down 34.36% YoY), while the FY2018 annual figure was 0.0, down 34.36% from the prior year.
- Debt Ratio fell to 0.0 in Q4 2018 per NAGE's latest filing, from 0.0 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.26 in Q1 2016 and bottomed at 0.0 in Q4 2018.
- Historically, Debt Ratio has averaged 0.07 across 3 years, with a median of 0.01 in 2016.
- Annual changes were most pronounced in 2016 — Debt Ratio plunged 93.3% — and 2018, when it slumped 34.36%.
- Niagen Bioscience's Debt Ratio stood at 0.02 in 2016, then sank by 71.62% to 0.0 in 2017, then plunged by 34.36% to 0.0 in 2018.
- Business Quant data shows NAGE's Debt Ratio at 0.0 in Q4 2018, 0.0 in Q4 2017, and 0.02 in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.12 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.47 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.26 |
| 10 | Niagen Bioscience | 238.30 Mn | 171.56 Mn | 19.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 0.00 |
| Dec 30, 2017 | 0.00 |
| Dec 31, 2016 | 0.02 |
| Jan 2, 2016 | 0.26 |